Susquehanna International »

Ernexa Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Ernexa Therapeutics (ERNA) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Ernexa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ernexa Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ernexa Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-09-30 $34k 31k 1.10

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
UnitedHealth (UNH)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)

View all positions for Susquehanna International

Top funds holding Ernexa Therapeutics

CI Private Wealth
Susquehanna International
Geode Capital Management
Vanguard Group
Sippican Capital Adivsors
Tower Research Capital
BlackRock
Morgan Stanley
Assetmark
EverSource Wealth Advisors
Bnp Paribas Arbitrage, Snc
A. Montag and Associates
Activest Wealth Management

View all funds holding Ernexa Therapeutics